The TNFRSF11B gene makes osteoprotegerin, a protein that helps control how quickly bone is broken down and rebuilt. This gene plays an important role in keeping the balance between normal bone repair and too much bone loss. If it does not work properly, bones may become weak, painful, or unusually shaped, and some people develop conditions such as early osteoporosis or juvenile Paget disease. The TNFRSF11B gene is mainly known in medical genetics rather than public culture.
What is a gene?
A gene is a stretch of DNA that gives your cells instructions they can use to make molecules or manage processes in the body. Some genes carry the directions for producing proteins, which are the parts of cells that do much of the work. Other genes mainly help regulate when certain processes happen, where they happen, and how strongly they occur. Taken together, genes affect how the body grows and works, and they can influence how you react to food, stress, or medications. To go deeper into this topic, you can find more in the LearnHub.
Overview
TNFRSF11BGene function
What if the gene works
The TNFRSF11B gene helps control bone remodeling. Its protein acts like a brake on bone breakdown by blocking signals that activate osteoclasts, the cells that remove bone.
Risk
What if the gene does not work
More disruptive variants in the TNFRSF11B gene can cause high bone turnover with bone pain, fractures, changes in bone shape, and hearing loss. Milder variants may have smaller effects or change when symptoms start and how pronounced they become.
Treatment
What does that mean for your treatment
No TNFRSF11B-specific treatment or drug selection is currently established in clinical guidelines. The TNFRSF11B gene is part of the RANK/RANKL bone pathway, which is being studied as a drug target and helps guide research on treatments that reduce bone breakdown.
Conditions associated with TNFRSF11B
Gene function
What if the gene works
Your bones are not fixed structures. Small areas are broken down and rebuilt all the time. The TNFRSF11B gene helps keep this process in balance by making a protein called osteoprotegerin. This supports bone health and normal bone remodeling throughout life.
This gene makes osteoprotegerin, a protein that helps balance the normal cycle of bone breakdown and rebuilding. It works by catching RANKL (a signal that tells bone breaking cells to get to work).
By limiting how strongly cells that break down bone are activated, the TNFRSF11B gene helps your skeleton hold on to the right amount of bone. This supports steady bone strength as old bone is replaced with new bone.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and help explain normal human diversity, including variations in appearance, metabolism, and the way the body responds to environmental factors. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. Sometimes, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TNFRSF11B gene can change how the osteoprotegerin protein is folded, released from cells, or able to bind RANKL, a signal that drives bone breakdown cells. This is the main way TNFRSF11B gene variants affect bone remodeling. Some variants leave part of the protein working, while more severe loss-of-function variants can remove most or all activity. That difference can shape how early bone changes appear and how marked they are in juvenile Paget disease.
How variants are linked to conditions
Pathogenic variants in the TNFRSF11B gene can cause juvenile Paget disease, a rare inherited bone condition that may lead to bone pain, changes in bone shape, and fractures in childhood. This TNFRSF11B gene variant and juvenile Paget disease link is well established. Some other TNFRSF11B variants have also been associated with bone mineral density and osteoporosis risk, but those findings describe risk, not a diagnosis.
A variant is not necessarily a diagnosis
Gene variants are a routine part of human biology and are found commonly in the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, especially when several genes and environmental influences play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce risk related to the TNFRSF11B gene itself. For many living with a TNFRSF11B change, overall bone health can still be shaped by age, hormones, activity level, calcium and vitamin D intake, and other medical conditions, so personal risk is best discussed with a doctor or genetic counselor.
Inheritance of TNFRSF11B variants
The TNFRSF11B gene inheritance pattern depends on the specific condition involved. For juvenile Paget disease linked to the TNFRSF11B gene, inheritance is autosomal recessive, which means a child inherits one altered copy from each parent, and parents are usually unaffected carriers. Some other TNFRSF11B-related bone and joint conditions have been reported with autosomal dominant inheritance, where one altered copy from either parent can be enough to cause the condition. In families with a dominant TNFRSF11B gene variant, each child has a 50% chance of inheriting that variant.
What does my TNFRSF11B result mean for my family?
For families with a disease-causing change in the TNFRSF11B gene, close relatives may also carry the same change. This gene is linked to a rare bone condition that usually appears when both copies of the gene are changed, so parents are often healthy carriers, and brothers or sisters may also be carriers or may be affected. Other relatives may also want to learn whether the change runs in the family.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a TNFRSF11B variant, a lab can analyze DNA from a blood sample, saliva, or a cheek swab. TNFRSF11B genetic testing looks for spelling changes in the TNFRSF11B gene and compares them with known variant databases. Results may show a benign variant, an uncertain finding, or a variant linked to bone conditions.
When should I consider getting a genetic test?
Testing for the TNFRSF11B gene may be worth discussing if a child or young adult has a rare inherited bone condition called juvenile Paget disease, especially with bone pain, bowed or enlarged bones, repeated fractures, or early hearing loss. It can also help when these problems run in the family or when blood tests show unusually high bone turnover.
A genetic result is only one part of your health story
How informative a genetic result is depends on both the condition and the type of variant involved, though it can provide meaningful insight. Over time, the way the body functions is shaped by many influences, including lifestyle, environment, age, and medical history. In conditions influenced by many genes, genetic information usually adds context rather than certainty and makes the most sense when viewed together with other parts of care. In other cases, the result may give a clear answer. In areas like medication response, genetic results can also help put a person’s experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, transports, or responds to a drug. This helps explain why the same treatment works well for one person, works less well for another, or causes more side effects in some people.
What is Pharmacogenetics?
Pharmacogenetics examines how differences in genes can affect the way someone responds to medication. It studies relationships between genes and drugs to help explain why treatments can work differently from one person to another. For many medicines, genes can influence how strongly a drug works or how the body handles it. This information can help support more informed, individualized treatment decisions. To explore this topic further, you can learn more in the LearnHub.
Drugs influenced by the TNFRSF11B gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices. For questions about medicines, side effects, or your overall health, talk with your doctor or pharmacist.
History
In the late 1990s, researchers identified the TNFRSF11B gene while studying how bone tissue is regulated and renewed. Initially understood only through visible traits, later recognized as tied to a specific gene, its discovery helped connect rare inherited bone conditions with a clearer biological cause. Around the same time, the protein made by this gene was given the name osteoprotegerin, which quickly became important in bone research. From these first observations, research expanded steadily, and scientists linked changes in the TNFRSF11B gene to uncommon conditions involving unusually dense bone and, in some families, hearing changes. These studies helped place the TNFRSF11B gene in the wider story of modern skeletal genetics.